{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=matching+placebo+twice+daily+%28BID%29&page=2", "query": { "intervention": "matching placebo twice daily (BID)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 1067, "total_pages": 107, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=matching+placebo+twice+daily+%28BID%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=matching+placebo+twice+daily+%28BID%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-10T01:08:59.003Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04223349", "title": "A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "JNJ-70033093", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 66, "start_date": "2020-01-10", "completion_date": "2020-04-08", "has_results": false, "last_update_posted_date": "2025-04-27", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04223349" }, { "nct_id": "NCT01020474", "title": "Adolescent Fibromyalgia Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "pregabalin (Lyrica)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 107, "start_date": "2010-05", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2021-01-28", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 30, "location_summary": "Los Angeles, California • Santa Ana, California • Delray Beach, Florida + 18 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Delray Beach", "state": "Florida" }, { "city": "Delray Beach", "state": "Florida" }, { "city": "Delray Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01020474" }, { "nct_id": "NCT01442038", "title": "Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Artery Disease", "Angina Pectoris" ], "interventions": [ { "name": "Ranolazine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2651, "start_date": "2011-10", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2016-07-15", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 86, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Scottsdale, Arizona + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01442038" }, { "nct_id": "NCT00687713", "title": "Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Methamphetamine Dependence" ], "interventions": [ { "name": "Bupropion", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Institute on Drug Abuse (NIDA)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 200, "start_date": "2008-05", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2017-03-21", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 12, "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Woodland Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00687713" }, { "nct_id": "NCT07227649", "title": "NAC-REPAIR for Post-surgical Pain", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carpal Tunnel Surgery", "Trigger Finger Disorder", "De Quervain Syndrome", "Guyon's Canal", "Dupuytren Contracture", "Morton Neuroma", "Tarsal Tunnel Syndrome", "Plantar Fasciopathy", "Peroneal Nerve Entrapment" ], "interventions": [ { "name": "NAC", "type": "DRUG" }, { "name": "NAC 0mg/day (Placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 80, "start_date": "2026-10-15", "completion_date": "2027-07-15", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07227649" }, { "nct_id": "NCT05279417", "title": "ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "ATI-450 50 mg oral tablet BID", "type": "DRUG" }, { "name": "Placebo oral tablet", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "ATI-450 20 mg oral tablet BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aclaris Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 251, "start_date": "2022-02-01", "completion_date": "2023-10-11", "has_results": true, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 11, "location_summary": "El Cajon, California • Encino, California • La Jolla, California + 8 more", "locations": [ { "city": "El Cajon", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05279417" }, { "nct_id": "NCT01466335", "title": "An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bone Marrow Transplantation" ], "interventions": [ { "name": "Ronacaleret (100mg tablet)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 39, "start_date": "2011-10-27", "completion_date": "2012-03-05", "has_results": false, "last_update_posted_date": "2017-06-20", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01466335" }, { "nct_id": "NCT03747458", "title": "OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bilateral Nasal Polyposis" ], "interventions": [ { "name": "OPN-375", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Optinose US Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 40, "start_date": "2018-12-31", "completion_date": "2026-06-11", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 22, "location_summary": "Gilbert, Arizona • Bakersfield, California • Fresno, California + 18 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03747458" }, { "nct_id": "NCT06143891", "title": "A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Graft Versus Host Disease" ], "interventions": [ { "name": "Belumosudil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 260, "start_date": "2024-01-23", "completion_date": "2028-09-29", "has_results": false, "last_update_posted_date": "2025-10-14", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 24, "location_summary": "Little Rock, Arkansas • Duarte, California • San Francisco, California + 21 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Duarte", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06143891" }, { "nct_id": "NCT02139046", "title": "Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gout" ], "interventions": [ { "name": "Febuxostat IR", "type": "DRUG" }, { "name": "Febuxostat XR", "type": "DRUG" }, { "name": "Febuxostat placebo", "type": "DRUG" }, { "name": "Colchicine", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Lansoprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1790, "start_date": "2014-04", "completion_date": "2015-11", "has_results": true, "last_update_posted_date": "2016-11-03", "last_synced_at": "2026-10-10T01:08:59.003Z", "location_count": 192, "location_summary": "Binghamton, Alabama • Birmingham, Alabama • Huntsville, Alabama + 189 more", "locations": [ { "city": "Binghamton", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02139046" } ] }